DE2511698C2 - Verfahren zur Bestimmung von menschlichem Choriongonadotropin (HCG), luteinisierendem Hormon (LH) oder dem menschlichen Choriongonadotropin ähnlichem Material, Reagenz zur Durchführung des Verfahrens und Verfahren zu dessen Herstellung - Google Patents
Verfahren zur Bestimmung von menschlichem Choriongonadotropin (HCG), luteinisierendem Hormon (LH) oder dem menschlichen Choriongonadotropin ähnlichem Material, Reagenz zur Durchführung des Verfahrens und Verfahren zu dessen HerstellungInfo
- Publication number
- DE2511698C2 DE2511698C2 DE2511698A DE2511698A DE2511698C2 DE 2511698 C2 DE2511698 C2 DE 2511698C2 DE 2511698 A DE2511698 A DE 2511698A DE 2511698 A DE2511698 A DE 2511698A DE 2511698 C2 DE2511698 C2 DE 2511698C2
- Authority
- DE
- Germany
- Prior art keywords
- human chorionic
- chorionic gonadotropin
- receptor
- hormone
- hcg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000011022 Chorionic Gonadotropin Human genes 0.000 title claims description 85
- 108010062540 Chorionic Gonadotropin Proteins 0.000 title claims description 85
- 229940084986 human chorionic gonadotropin Drugs 0.000 title claims description 83
- 238000000034 method Methods 0.000 title claims description 61
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 12
- 239000000463 material Substances 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 102000009151 Luteinizing Hormone Human genes 0.000 title description 14
- 108010073521 Luteinizing Hormone Proteins 0.000 title description 14
- 229940040129 luteinizing hormone Drugs 0.000 title description 14
- 230000008569 process Effects 0.000 title description 7
- 229940088597 hormone Drugs 0.000 claims description 37
- 239000005556 hormone Substances 0.000 claims description 37
- 241001465754 Metazoa Species 0.000 claims description 27
- 210000000170 cell membrane Anatomy 0.000 claims description 15
- 230000027455 binding Effects 0.000 claims description 13
- 210000004246 corpus luteum Anatomy 0.000 claims description 10
- 241000124008 Mammalia Species 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 241000283073 Equus caballus Species 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 62
- 230000035935 pregnancy Effects 0.000 description 47
- 239000000523 sample Substances 0.000 description 25
- 230000016087 ovulation Effects 0.000 description 13
- 210000002700 urine Anatomy 0.000 description 13
- 230000000984 immunochemical effect Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 9
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 9
- 229940028334 follicle stimulating hormone Drugs 0.000 description 9
- 238000009597 pregnancy test Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 210000001672 ovary Anatomy 0.000 description 7
- 238000010998 test method Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000011835 investigation Methods 0.000 description 6
- 230000002611 ovarian Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004816 latex Substances 0.000 description 5
- 229920000126 latex Polymers 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 206010000234 Abortion spontaneous Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 208000000995 spontaneous abortion Diseases 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001456 gonadotroph Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000001135 Friedman test Methods 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007978 cacodylate buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000007705 chemical test Methods 0.000 description 2
- 229940015047 chorionic gonadotropin Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000003511 ectopic pregnancy Diseases 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012956 testing procedure Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 229920003319 Araldite® Polymers 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- 208000012266 Needlestick injury Diseases 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ILVGMCVCQBJPSH-WDSKDSINSA-N Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO ILVGMCVCQBJPSH-WDSKDSINSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000003329 adenohypophysis hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 238000011551 log transformation method Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940108519 trasylol Drugs 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/834—Urine; urinary system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
- Y10S530/853—Ovary; eggs; embryos
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45414574A | 1974-03-22 | 1974-03-22 | |
| US05/522,760 US4016250A (en) | 1974-03-22 | 1974-11-11 | Method for testing for pregnancy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2511698A1 DE2511698A1 (de) | 1975-11-06 |
| DE2511698C2 true DE2511698C2 (de) | 1984-07-12 |
Family
ID=27037352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2511698A Expired DE2511698C2 (de) | 1974-03-22 | 1975-03-18 | Verfahren zur Bestimmung von menschlichem Choriongonadotropin (HCG), luteinisierendem Hormon (LH) oder dem menschlichen Choriongonadotropin ähnlichem Material, Reagenz zur Durchführung des Verfahrens und Verfahren zu dessen Herstellung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4016250A (enExample) |
| JP (1) | JPS514895A (enExample) |
| AU (1) | AU502577B2 (enExample) |
| CA (1) | CA1067002A (enExample) |
| DE (1) | DE2511698C2 (enExample) |
| FR (1) | FR2265099B1 (enExample) |
| GB (1) | GB1508221A (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138214A (en) * | 1977-12-19 | 1979-02-06 | American Home Products Corporation | Diagnostic test utilizing human chorionic gonadotropin |
| US4313871A (en) * | 1978-02-06 | 1982-02-02 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4234561A (en) * | 1978-02-06 | 1980-11-18 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4292296A (en) * | 1978-09-12 | 1981-09-29 | Baxter Travenol Laboratories, Inc. | Diagnostic method |
| IL56342A (en) * | 1978-12-29 | 1982-05-31 | Zer Tamar | Method and means for determining human chorionic gonadotropin in urine |
| US4332784A (en) * | 1979-02-06 | 1982-06-01 | The Radiochemical Centre Limited | Dual isotope assays |
| US4268435A (en) * | 1979-02-06 | 1981-05-19 | Research Corporation | Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine |
| US4310455A (en) * | 1979-04-17 | 1982-01-12 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4327178A (en) * | 1979-05-01 | 1982-04-27 | University Of Miami | Urinary kallikrein assay: specific substrates and assay method |
| US4378344A (en) * | 1979-09-28 | 1983-03-29 | Ventrex Laboratories, Inc. | Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system |
| NL8000173A (nl) * | 1980-01-11 | 1981-08-03 | Akzo Nv | Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen. |
| US4560649A (en) * | 1981-10-15 | 1985-12-24 | Cornell Research Foundation | Assaying for hLH or hCG with immobilized hormone receptors |
| US4543339A (en) * | 1982-03-16 | 1985-09-24 | Oneill Christopher | Early pregnancy detection by detecting enhanced blood platelet activation |
| US4966888A (en) * | 1985-07-08 | 1990-10-30 | Cornell Research Foundation, Inc. | hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
| US4921808A (en) * | 1986-06-25 | 1990-05-01 | The Albany Medical College Of Union University | Method for determining follicle stimulating hormone |
| US5225330A (en) * | 1988-08-01 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
| ES2084689T5 (es) * | 1989-01-17 | 2005-03-01 | James N. Macri | Metodo para la averiguacion del sindrome de down. |
| US5324667A (en) * | 1989-01-17 | 1994-06-28 | Macri James N | Method for detecting down sydrown by non-invasive maternal blood screening |
| US5258907A (en) * | 1989-01-17 | 1993-11-02 | Macri James N | Method and apparatus for detecting down syndrome by non-invasive maternal blood screening |
| US5252489A (en) * | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
| FI82144C (fi) * | 1989-03-22 | 1991-01-10 | Wallac Oy | Foerfarande foer samtidig bestaemning av flera ligander. |
| US6182665B1 (en) * | 1997-06-02 | 2001-02-06 | Brigham And Women's Hospital | Maternal immune responsiveness as a predictor of pregnancy outcome |
| US6165796A (en) * | 1997-11-26 | 2000-12-26 | Beckman Coulter, Inc. | Pipettable ion detector and method |
| KR100403871B1 (ko) * | 2000-08-12 | 2003-11-01 | 휴마시스 주식회사 | 정상 임신과 자궁외 임신을 진단하는 장치 및 이의제조방법 |
| DE10211818B4 (de) * | 2002-03-16 | 2006-07-06 | peS Gesellschaft für medizinische Diagnose-Systeme mbH | Verfahren zur quantitativen Bestimmung mehrerer Analyten |
| US7101847B2 (en) * | 2002-10-11 | 2006-09-05 | Milkhaus Laboratory, Inc. | Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin |
| US7029855B1 (en) * | 2003-01-28 | 2006-04-18 | Proteomyx Inc. | Radioactive multiplexing analytical methods for biomarkers discovery |
| CA2542018A1 (en) * | 2003-10-07 | 2005-05-19 | Nathaniel Tue Tran | Radioactive multiplexing analytical methods |
| US20050196812A1 (en) * | 2004-03-05 | 2005-09-08 | Williams David E. | Determining the estimated date of embryo implantation and related dates |
| RU2688693C1 (ru) * | 2018-03-19 | 2019-05-22 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ морфологического определения срока беременности |
| CN111596074B (zh) * | 2020-06-04 | 2023-05-02 | 昆明天沃生物科技有限公司 | 一种检测牛生育能力的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3203540A (en) * | 1962-12-28 | 1965-08-31 | Miles Lab | Test kit |
-
1974
- 1974-11-11 US US05/522,760 patent/US4016250A/en not_active Expired - Lifetime
-
1975
- 1975-03-17 AU AU79175/75A patent/AU502577B2/en not_active Expired
- 1975-03-18 DE DE2511698A patent/DE2511698C2/de not_active Expired
- 1975-03-19 JP JP50033463A patent/JPS514895A/ja active Granted
- 1975-03-21 GB GB11848/75A patent/GB1508221A/en not_active Expired
- 1975-03-21 CA CA223,186A patent/CA1067002A/en not_active Expired
- 1975-03-21 FR FR7508921A patent/FR2265099B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS514895A (en) | 1976-01-16 |
| JPS6119268B2 (enExample) | 1986-05-16 |
| GB1508221A (en) | 1978-04-19 |
| AU502577B2 (en) | 1979-08-02 |
| FR2265099B1 (enExample) | 1981-11-13 |
| DE2511698A1 (de) | 1975-11-06 |
| FR2265099A1 (enExample) | 1975-10-17 |
| US4016250A (en) | 1977-04-05 |
| AU7917575A (en) | 1976-09-23 |
| CA1067002A (en) | 1979-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2511698C2 (de) | Verfahren zur Bestimmung von menschlichem Choriongonadotropin (HCG), luteinisierendem Hormon (LH) oder dem menschlichen Choriongonadotropin ähnlichem Material, Reagenz zur Durchführung des Verfahrens und Verfahren zu dessen Herstellung | |
| DE69433504T2 (de) | ALPHAvBETA3 INTEGRIN ALS INDIKATOR FÜR ENDOMETRIOSE | |
| DE69404451T2 (de) | Prüfung zur vorhersage des ergebnisses von ivf | |
| Garth Sasser et al. | Detection of pregnancy by radioimmunoassay of a novel pregnancy-specific protein in serum of cows and a profile of serum concentrations during gestation | |
| Pauerstein et al. | Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates | |
| Robertson et al. | Plasma concentrations of progesterone, oestrone, oestradiol-17β and of oestrone sulphate in the pig at implantation, during pregnancy and at parturition | |
| DE2548868C2 (de) | Verfahren zur Bestimmung von Schwangerschaftshormonen | |
| DE69230890T2 (de) | Bestimmung von nukleären matrixproteinen in flüssigkeiten | |
| DE60120487T2 (de) | Verfahren zur detektion von vitamin d metaboliten | |
| Skemesh et al. | Early pregnancy diagnosis based upon plasma progesterone levels in the cow and ewe | |
| Koninckx et al. | Prolactin concentration in vaginal fluid: a new method for diagnosing ruptured membranes | |
| DE69328301T2 (de) | Diagnostisches verfahren zur bestimmung, ob die entbindung bevorsteht, und reagenzkit zur verwendung dafür | |
| DE69124511T2 (de) | Verfahren für den nachweis und/oder die bestimmung von hormonen | |
| Möstl et al. | Pregnancy diagnosis in cows and heifers by determination of oestradiol-17α in faeces | |
| Grudzinskas et al. | Circulating levels of pregnancy‐specific β1‐glycoprotein in early pregnancy | |
| Hoffmann et al. | Determination of progesterone in milk applied for pregnancy diagnosis in the cow | |
| DE69605294T2 (de) | Schnelle assays zur bestimmung des organzustands basierend auf dem nachweis eines oder mehrerer isoenzyme von glutathion-s-transferase | |
| DE69222991T2 (de) | Immunoassay für freie Analyten | |
| Glatstein et al. | Ontogeny of the estrogen receptor in the human fetal uterus | |
| DE69131237T2 (de) | Hormonnachweisverfahren. | |
| EP0267355B1 (de) | Verfahren zum Identifizieren gewebstypischer, unlöslicher Cytoskelettproteine | |
| DE3780446T2 (de) | Verfahren zur feststellung von schwangerschaftsstoerungen. | |
| AT407675B (de) | Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen | |
| Schneyer et al. | Radioimmunoassay of serum follicle-stimulating hormone and luteinizing hormone in the bottlenosed dolphin | |
| De Montigny et al. | Milk fat progesterone concentrations in goats and early pregnancy diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8125 | Change of the main classification |
Ipc: G01N 33/76 |
|
| AG | Has addition no. |
Ref country code: DE Ref document number: 2548868 Format of ref document f/p: P |
|
| D2 | Grant after examination | ||
| AG | Has addition no. |
Ref country code: DE Ref document number: 2548868 Format of ref document f/p: P |
|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |